news

Norma Completes Quantum AI Algorithm Validation on NVIDIA

"Quantum AI up to 73x Faster on NVIDIA CUDA-Q" Norma, a quantum computing company, has validated the performance of quantum…

3 months ago

StockGro Launches Stoxo: India’s First Stock Market AI Research Platform That Turns Confusion into Conviction

BENGALURU, India, Sept. 1, 2025 /PRNewswire/ -- StockGro, India's leading investment advisory and knowledge platform, today announced the launch of Stoxo…

3 months ago

Celebrating India’s Retail Heroes with Coca-Cola’s ‘Locally Yours’ Campaign

NEW DELHI, Sept. 1, 2025 /PRNewswire/ -- The first to open, the last to close, and always at the center…

3 months ago

Vantage Marks Strong Presence at Cripto Latin Fest 2025 in Medelln

PORT VILA, Vanuatu, Sept. 1, 2025 /PRNewswire/ -- Vantage Markets proudly participated as a sponsor at the eighth edition of Cripto…

3 months ago

Redseer Forecasts The Best Festive Period for E-commerce in the Last 5 Years, GMV to cross 1.15 Trillion

BENGALURU, India, Sept. 1, 2025 /PRNewswire/ -- India's festive economy in 2025 is shaping up to be the one of…

3 months ago

Nippon Life India Asset Management (NAM India) Strengthening Indo-Japan Ties: Sundeep Sikka

MUMBAI, India, Sept. 1, 2025 /PRNewswire/ -- Nippon Life India Asset Management CEO Represents India at India–Japan Economic Forum in…

3 months ago

SPJIMR WISE Tech leads dialogue on sustainable consumption

84% of Indians prefer sustainable products, but an 'intent–action gap' remains MUMBAI, India, Sept. 1, 2025 /PRNewswire/ -- Bharatiya Vidya Bhavan's…

3 months ago

Tescan Unveils New Global Brand Platform “The Art of Discovery” with APAC Rollout at SEMICON Taiwan

KARLSRUHE, Germany, BRNO, Czech Republic and TAIPEI, Sept. 1, 2025 /PRNewswire/ -- Tescan Group proudly introduces its new global brand platform The…

3 months ago

Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences

ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis…

3 months ago

Boehringers HERNEXEOS approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC

This press release is not intended for UK and US media.  HERNEXEOS® (zongertinib tablets) has been approved based on an objective…

3 months ago